M29* (p.Met29Ter) variant of HLA-B (P01889)
M29* (p.Met29Ter) in HLA-B (P01889) is a protein-truncating change. Clinical records from UniProt describe it as variant assessed as somatic; high impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.24 / 1. The record also includes population frequency data and structural context.
M29* (p.Met29Ter) variant details
- p.Met29Ter
- NCI-TCGA TCGA novel
- Variant assessed as somatic; high impact.
- Stop Gained
- Variant Prioritization Score for Impact Estimate 0.242
- CADD 22.80
- UniProt: Variant assessed as somatic; high impact.
- Population evidence available
- Structural context available